{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T17:42:28Z","timestamp":1784569348746,"version":"3.55.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","jaad.org","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jaad.2024.07.1503","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T02:26:15Z","timestamp":1724379975000},"page":"1094-1103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Prevalence and clinical impact of topical corticosteroid phobia among patients with chronic hand eczema\u2014Findings from the Danish Skin Cohort"],"prefix":"10.1016","volume":"91","author":[{"given":"Maria O.","family":"Christensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Sieborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea K.","family":"Nymand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Guttman-Yassky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Ezzedine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Schlapbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Molin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Zachariae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon F.","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob P.","family":"Thyssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Egeberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 3","key":"10.1016\/j.jaad.2024.07.1503_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-3083.2010.03615.x","article-title":"Redefining treatment options in chronic hand eczema (CHE)","volume":"24","author":"Bissonnette","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.jaad.2024.07.1503_bib2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2310\/7750.2010.09094","article-title":"Canadian hand dermatitis management guidelines","volume":"14","author":"Lynde","year":"2010","journal-title":"J Cutan Med Surg"},{"issue":"5","key":"10.1016\/j.jaad.2024.07.1503_bib3","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/cod.14035","article-title":"Guidelines for diagnosis, prevention, and treatment of hand eczema","volume":"86","author":"Thyssen","year":"2022","journal-title":"Contact Dermatitis"},{"issue":"6","key":"10.1016\/j.jaad.2024.07.1503_bib4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/cod.13804","article-title":"Prevalence, incidence, and severity of hand eczema in the general population \u2013 a systematic review and meta-analysis","volume":"84","author":"Quaade","year":"2021","journal-title":"Contact Dermatitis"},{"issue":"2","key":"10.1016\/j.jaad.2024.07.1503_bib5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1600-0536.2009.01669.x","article-title":"The epidemiology of hand eczema in the general population \u2013 prevalence and main findings","volume":"62","author":"Thyssen","year":"2010","journal-title":"Contact Dermatitis"},{"issue":"1","key":"10.1016\/j.jaad.2024.07.1503_bib6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1600-0536.2008.01362.x","article-title":"Hand eczema severity and quality of life: a cross-sectional, multicentre study of hand eczema patients","volume":"59","author":"Agner","year":"2008","journal-title":"Contact Dermatitis"},{"issue":"2","key":"10.1016\/j.jaad.2024.07.1503_bib7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2133.2009.09099.x","article-title":"Hand eczema and quality of life: a population-based study","volume":"161","author":"Moberg","year":"2009","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2024.07.1503_bib8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1001\/archderm.142.3.305","article-title":"Prognosis of occupational hand eczema: a follow-up study","volume":"142","author":"Cvetkovski","year":"2006","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2024.07.1503_bib9","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1046\/j.1365-2133.1999.02819.x","article-title":"Long-term, intermittent treatment of chronic hand eczema with mometasone furoate","volume":"140","author":"Veien","year":"1999","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2024.07.1503_bib10","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1046\/j.1365-2133.2003.05729.x","article-title":"Novel treatment of chronic severe hand dermatitis with bexarotene gel","volume":"150","author":"Hanifin","year":"2004","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2024.07.1503_bib11","article-title":"Interventions for hand eczema","volume":"4","author":"Christoffers","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaad.2024.07.1503_bib12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jdin.2023.11.004","article-title":"Adverse events from topical corticosteroid use in chronic hand eczema \u2013 findings from the Danish Skin Cohort","volume":"14","author":"Egeberg","year":"2024","journal-title":"JAAD Int"},{"issue":"8","key":"10.1016\/j.jaad.2024.07.1503_bib13","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1346-8138.1991.tb03115.x","article-title":"Modulation of epidermal terminal differentiation in patients after long-term topical corticosteroids","volume":"18","author":"Sheu","year":"1991","journal-title":"J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2024.07.1503_bib14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1034\/j.1600-0846.2001.70203.x","article-title":"Corticosteroid-induced atrophy and barrier impairment measured by non-invasive methods in human skin","volume":"7","author":"Kolbe","year":"2001","journal-title":"Skin Res Technol"},{"issue":"1","key":"10.1016\/j.jaad.2024.07.1503_bib15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1600-0536.2011.01967.x","article-title":"Immediate and delayed allergic hypersensitivity to corticosteroids: practical guidelines","volume":"66","author":"Baeck","year":"2012","journal-title":"Contact Dermatitis"},{"issue":"10","key":"10.1016\/j.jaad.2024.07.1503_bib17","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1001\/jamadermatol.2017.2437","article-title":"Topical corticosteroid phobia in atopic dermatitis: a systematic review","volume":"153","author":"Li","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2024.07.1503_bib18","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/09546634.2016.1201189","article-title":"Assessment of \u201ccorticophobia\u201d as an indicator of non-adherence to topical corticosteroids: a pilot study","volume":"28","author":"Mueller","year":"2017","journal-title":"J Dermatolog Treat"},{"issue":"4","key":"10.1016\/j.jaad.2024.07.1503_bib19","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1159\/000446068","article-title":"Topical corticosteroid concerns in dermatological outpatients: a cross-sectional and interventional study","volume":"232","author":"M\u00fcller","year":"2016","journal-title":"Dermatology"},{"issue":"5","key":"10.1016\/j.jaad.2024.07.1503_bib20","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1046\/j.1365-2133.2000.03473.x","article-title":"Topical corticosteroid phobia in patients with atopic eczema","volume":"142","author":"Charman","year":"2000","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2024.07.1503_bib21","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1365-2133.2011.10449.x","article-title":"Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency","volume":"165","author":"Aubert-Wastiaux","year":"2011","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2024.07.1503_bib22","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.1111\/jdv.13961","article-title":"Monitoring of topical corticosteroid phobia in a population of parents with children with atopic dermatitis using the TOPICOP\u00ae scale: prevalence, risk factors and the impact of therapeutic patient education","volume":"31","author":"Gonzales","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"29-30","key":"10.1016\/j.jaad.2024.07.1503_bib23","first-page":"509","article-title":"The diagnosis and graded therapy of atopic dermatitis","volume":"111","author":"Werfel","year":"2014","journal-title":"Dtsch Arztebl Int"},{"issue":"3","key":"10.1016\/j.jaad.2024.07.1503_bib24","first-page":"250","article-title":"Treatment of atopic dermatitis in the United States: analysis of data from the National Ambulatory Medical Care Survey","volume":"16","author":"McGregor","year":"2017","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2024.07.1503_bib25","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s40257-021-00623-6","article-title":"Steroid phobia: a review of prevalence, risk factors, and interventions","volume":"22","author":"Contento","year":"2021","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2024.07.1503_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028116","article-title":"Prevalence and characteristics of psoriasis in Denmark: findings from the Danish Skin Cohort","volume":"9","author":"Egeberg","year":"2019","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.jaad.2024.07.1503_bib27","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/cod.14456","article-title":"Demographics, characteristics and medical treatment among adults with hand eczema in Denmark. A cross-sectional validation and registry-based study","volume":"90","author":"Christensen","year":"2024","journal-title":"Contact Dermatitis"},{"issue":"2","key":"10.1016\/j.jaad.2024.07.1503_bib28","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2133.2004.06270.x","article-title":"Construction and validation of a photographic guide for assessing severity of chronic hand dermatitis","volume":"152","author":"Coenraads","year":"2005","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2024.07.1503_bib29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2133.2006.07565.x","article-title":"Severity of hand eczema assessed by patients and dermatologist using a photographic guide","volume":"156","author":"Hald","year":"2007","journal-title":"Br J Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2024.07.1503_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076493","article-title":"TOPICOP\u00a9: a new scale evaluating topical corticosteroid phobia among atopic dermatitis outpatients and their parents","volume":"8","author":"Moret","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jaad.2024.07.1503_bib31","doi-asserted-by":"crossref","first-page":"149","DOI":"10.11622\/smedj.2019110","article-title":"Corticosteroid phobia: a questionnaire study using TOPICOP score","volume":"61","author":"Choi","year":"2020","journal-title":"Singapore Med J"},{"issue":"7","key":"10.1016\/j.jaad.2024.07.1503_bib32","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/bcp.14193","article-title":"The Medication Adherence Report Scale: a measurement tool for eliciting patients\u2019 reports of nonadherence","volume":"86","author":"Chan","year":"2020","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.jaad.2024.07.1503_bib33","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1186\/s12885-017-3735-1","article-title":"Prevalence and associated factors of medication non-adherence in hematological-oncological patients in their home situation","volume":"17","author":"Bouwman","year":"2017","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.jaad.2024.07.1503_bib34","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaad.2014.03.023","article-title":"Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies","volume":"71","author":"Eichenfield","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2024.07.1503_bib35","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s40257-017-0318-5","article-title":"Topical corticosteroid concerns among parents of children with psoriasis versus atopic dermatitis: a French Multicenter Cross-Sectional Study","volume":"19","author":"Moawad","year":"2018","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2024.07.1503_bib36","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/ajd.12313","article-title":"Adverse effects of topical corticosteroids in paediatric eczema: Australasian consensus statement","volume":"56","author":"Mooney","year":"2015","journal-title":"Australas J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2024.07.1503_bib37","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jamadermatol.2020.4968","article-title":"Association of potent and very potent topical corticosteroids and the risk of osteoporosis and major osteoporotic fractures","volume":"157","author":"Egeberg","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2024.07.1503_bib38","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.2337\/dc18-2158","article-title":"Association between topical corticosteroid use and type 2 diabetes in two European population-based adult cohorts","volume":"42","author":"Andersen","year":"2019","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.jaad.2024.07.1503_bib39","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2340\/00015555-2157","article-title":"Corticosteroid phobia among pharmacists regarding atopic dermatitis in children: a national French survey","volume":"96","author":"Raffin","year":"2016","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"10.1016\/j.jaad.2024.07.1503_bib40","first-page":"335","article-title":"General practitioners knowledge about use of topical corticosteroids in paediatric atopic dermatitis in Australia","volume":"46","author":"Smith","year":"2017","journal-title":"Aust Fam Physician"},{"issue":"3","key":"10.1016\/j.jaad.2024.07.1503_bib41","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1440-0960.2010.00636.x","article-title":"Corticosteroid phobia and other confounders in the treatment of childhood atopic dermatitis explored using parent focus groups","volume":"51","author":"Smith","year":"2010","journal-title":"Australas J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2024.07.1503_bib42","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/09546634.2016.1213353","article-title":"Evaluation of the influence of pharmacists and GPs on patient perceptions of long-term topical corticosteroid use","volume":"28","author":"Farrugia","year":"2017","journal-title":"J Dermatolog Treat"},{"issue":"4","key":"10.1016\/j.jaad.2024.07.1503_bib43","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1159\/000534766","article-title":"Topical corticosteroid phobia among Danish pharmacy staff","volume":"240","author":"Toft-Hansen","year":"2024","journal-title":"Dermatology"},{"issue":"5","key":"10.1016\/j.jaad.2024.07.1503_bib44","doi-asserted-by":"crossref","first-page":"499","DOI":"10.5021\/ad.2015.27.5.499","article-title":"Topical corticosteroid phobia among parents of children with atopic eczema in Korea","volume":"27","author":"Lee","year":"2015","journal-title":"Ann Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2024.07.1503_bib45","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.0906-6705.2006.00435.x","article-title":"Glucocorticoid therapy-induced skin atrophy","volume":"15","author":"Schoepe","year":"2006","journal-title":"Exp Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2024.07.1503_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2005.01.010","article-title":"Adverse effects of topical glucocorticosteroids","volume":"54","author":"Hengge","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2024.07.1503_bib47","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/jid.2009.210","article-title":"Dermal hyaluronan is rapidly reduced by topical treatment with glucocorticoids","volume":"130","author":"Gebhardt","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2024.07.1503_bib48","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.2147\/CCID.S224211","article-title":"Glucocorticoid-induced skin atrophy: the old and the new","volume":"13","author":"Niculet","year":"2020","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2024.07.1503_bib49","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1365-2133.2011.10530.x","article-title":"Filaggrin loss-of-function mutation R501X and 2282del4 carrier status is associated with fissured skin on the hands: results from a cross-sectional population study","volume":"166","author":"Thyssen","year":"2012","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2024.07.1503_bib51","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1111\/all.13189","article-title":"Topical corticosteroid phobia in atopic dermatitis: international feasibility study of the TOPICOP score","volume":"72","author":"Stalder","year":"2017","journal-title":"Allergy"},{"issue":"7","key":"10.1016\/j.jaad.2024.07.1503_bib52","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/00016357.2020.1739329","article-title":"Validity, reliability and optimisation of the TOPICOP questionnaire for oral lichen planus","volume":"78","author":"Lorenzo-Pouso","year":"2020","journal-title":"Acta Odontol Scand"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962224027117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962224027117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T07:47:13Z","timestamp":1732088833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962224027117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0190962224027117"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2024.07.1503","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and clinical impact of topical corticosteroid phobia among patients with chronic hand eczema\u2014Findings from the Danish Skin Cohort","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2024.07.1503","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}